Related Experiment Video
Updated: Mar 16, 2026

Mouse Models Of Helicobacter Infection And Gastric Pathologies
Published on: October 18, 2018
Other Helicobacters and gastric microbiota
Chloë De Witte1, Christian Schulz2, Annemieke Smet1
1Department of Pathology, Bacteriology and Avian Diseases, Faculty of Veterinary Medicine, Ghent University, Ghent, Belgium.
This review highlights recent advances in understanding non-Helicobacter pylori Helicobacter species (NHPH) infections and their pathogenesis. Whole-genome sequencing is key for NHPH identification, with potential vaccination strategies emerging.
Area of Science:
- Microbiology
- Gastroenterology
- Infectious Diseases
Background:
- Non-Helicobacter pylori Helicobacter species (NHPH) are increasingly implicated in human infections, notably H. cinaedi causing severe bacteremia.
- Gastric microbiota interactions with H. pylori are complex and influence disease outcomes.
- NHPH presence in animal models can confound experimental results, necessitating screening and eradication.
Purpose of the Study:
- To review 2015 literature on gastric and enterohepatic NHPH.
- To summarize gastric microbiota interactions with H. pylori.
- To detail NHPH pathogenesis and potential therapeutic strategies.
Main Methods:
- Literature review of studies published in 2015.
- Analysis of recent findings on NHPH identification and virulence factors.
- Exploration of high-throughput sequencing for microbiota analysis.
Main Results:
- Whole-genome sequencing is the most reliable method for NHPH species identification.
- Virulence factors like outer membrane proteins and phospholipase C-gamma 2 are linked to gastric colonization and gastritis.
- Alterations in gastric microbiota due to H. pylori infection may elevate gastric cancer risk.
Conclusions:
- NHPH infections are a growing concern, requiring better diagnostic and therapeutic approaches.
- Vaccination strategies and glutathione supplementation show promise for managing gastric NHPH infections.
- Understanding gastric microbiota dynamics is crucial for preventing H. pylori-associated diseases.
Related Concept Videos
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
What is Monogastric Digestion?
Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.

